Antiretroviral therapy (ART) has led to increased survival
of children with vertically acquired human immunodeficiency virusinfection.
Significant morbidity arises from respiratory symptoms, but aetiology and
pulmonary function abnormalities have not been systematically studied.
Human immunodeficiency virus-positive children aged 8-16 years were
systematically recruited within clinics in Blantyre, Malawi. Clinical review,
quality of life assessment, spirometry, and chest radiography were performed.
One hundred sixty participants had a mean of age 11.1
(range, 8-16) years and 50.0% were female. Cough was present in 60 (37.5%)
participants, and 55 (34.4%) had moderate or severe dyspnoea. Thirty-four
(22.1%) participants had digital clubbing. Thirty-three (20.6%) participants
were hypoxic at rest. One hundred eighteen (73.8%) of the children were
receiving ART; median CD4 count was 698 cells/µL in these compared with 406
cells/µL in ART-naive individuals (P < .001). From 145 spirometry traces
(90.6%), mean forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) were
1.06 and 0.89 standard deviations below predicted mean, respectively.
Twenty-one (14.5%) traces demonstrated obstructive defects and 26 (17.9%)
reduced FVC. Lung function abnormality was not associated with any clinical
findings. Of the 51 individuals with abnormal lung function, the mean increase
in FEV1 after salbutamol was 3.8% (95% confidence
interval, 0.02-7.53). "Tramlines" and ring shadows were seen on chest
radiographs in over half of cases.
Symptoms of chronic lung
disease were highly prevalent with 2 main clinical phenotypes:
"cough" and "hypoxia". Lung function abnormalities are
common, poorly responsive to bronchodilators, and apparent throughout the age range
of our cohort. Pathological causes remain to be elucidated. Cough and hypoxic
phenotypes could be a useful part of diagnostic algorithms if further validated.
Below: Proposed CLD phenotypes. Proportional areas diagram illustrating the proposed CLD phenotypes, “cough” and “hypoxia”, and their overlap with individuals with abnormal spirometry. Percentages indicate the proportion of the entire study population for which spirometry data were available.
Below: Spirometry results overview. Graphs illustrating the degree and distribution of spirometric abnormality. (A) Boxes represent 25th and 75th percentiles, whiskers represent 10th and 90th percentiles, with outliers shown as individual dots. Upper limit of normal (ULN) and lower limit of normal (LLN) drawn by dashed line at +1.64 standard deviation (SD) and −1.64 SD from the mean, respectively. (B) Forced expiratory volume (FEV1) z-score for all participants as a function of age. Linear regression model is shown as a solid line. There is a nonsignificant tendency to reducing FEV1 with increasing age in this cohort (r2 = 0.026; P = .054). Similar results for forced vital capacity obtained (results not shown).
Read full article
at: http://goo.gl/OQ0gpl
By:
- 1College of Medicine, University of Malawi London School of Hygiene & Tropical Medicine, United Kingdom.
- 2College of Medicine, University of Malawi.
- 3London School of Hygiene & Tropical Medicine, United Kingdom.
- 4Medical Research Council Unit, Gambia.
- 5College of Medicine, University of Malawi University of St Andrews, United Kingdom.
- 6College of Medicine, University of Malawi Dignitas International, Zomba, Malawi.
- 7Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre Liverpool School of Tropical Medicine, United Kingdom.
No comments:
Post a Comment